Divergent effects of estradiol on gene expression of catecholamine biosynthetic enzymes.
Within the catecholaminergic systems, there are contradictory findings regarding ability of estradiol to regulate expression of genes related to catecholamine biosynthesis. Several parameters important for effects of estradiol on the catecholamine (CA) related enzyme gene expression were examined in two CA regions. Ovariectomized (OVX) female rats were given prolonged estradiol treatments, either in a pulsatile fashion by injections or continuously by pellets. The mode affected the response of tyrosine hydroxylase (TH) and GTP cyclohydrolase I (GTPCH) mRNAs differentially in the nucleus of solitary tract (NTS) and the locus coeruleus (LC). In rostral-medial NTS, TH mRNA levels were increased with injections, but declined in rats administered estradiol by pellets. In LC, a significant change was only observed in GTPCH with injections. These differences may reflect activation of different estrogen receptors (ER). The response to estradiol in the presence of ERalpha and ER beta was examined in PC12 cell culture. Estradiol directly regulated promoter activity of TH, GTPCH and dopamine beta-hydroxylase (DBH) genes. With ERalpha, 17 beta-estradiol elevated TH promoter activity, while there was a decline with ERbeta. In contrast, both DBH and GTPCH promoters were enhanced by 17 beta-estradiol over a wide range of concentrations with either ER subtype. Thus, mode of administration, location examined and ER subtype expressed are important considerations in the overall response of catecholamine related enzymes to estradiol.
Sabban
Esther L
EL
Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, New York 10595, USA. Esther_Sabban@nymc.edu
Maharjan
Shreekrishna
S
Nostramo
Regina
R
Serova
Lidia I
LI
D000704:Analysis of Variance; D000818:Animals; D004299:Dopamine beta-Hydroxylase / Q000235:genetics / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D004967:Estrogens / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006136:GTP Cyclohydrolase / Q000235:genetics / Q000378:metabolism*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D008125:Locus Coeruleus / Q000187:drug effects / Q000201:enzymology; D010052:Ovariectomy / Q000379:methods; D016716:PC12 Cells; D012333:RNA, Messenger / Q000378:metabolism; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats; D017552:Solitary Nucleus / Q000187:drug effects / Q000201:enzymology; D013997:Time Factors; D014162:Transfection / Q000379:methods; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics / Q000378:metabolism*
D004967:Estrogens; D012333:RNA, Messenger; D004958:Estradiol; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D006136:GTP Cyclohydrolase